A new poll shows an overhwhelming majority of Marylanders believe drug makers could reduce costs for prescription drugs ...

Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

The pharmaceutical industry argues that lower prices will have catastrophic effects on research and development, while other suggest that curbing drug prices will result in only modest cuts in the ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...

A few months ago, a friend of mine contracted covid. Soon after, her medical insurance company issued a statement stating they had paid the drug company $1,453.55 for the Paxlovid treatment. The high ...